Search Results 401-410 of 17868 for monoclonal antibody

  1. A Study Evaluating Pembrolizumab and Epacadostat in Treating Participants With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma - Mayo Clinic

    Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of ... History of severe hypersensitivity reaction to any monoclonal antibody.

  2. Mayo Clinic Q & A - Dr. Gregory Poland COVID-19 Update 01 03...

    The extraordinary mutation of the Omicron variant has caused us to lose two sets of monoclonal antibodies, leaving us with one monoclonal antibody for ...

  3. A Study of Idelalisib Combined with BI 836826 for Patients with Chronic Lymphocytic Leukemia - Mayo Clinic

    About this study. The purpose of this study is to evaluate the safety and tolerability of the combination of idelallisib with the monoclonal antibody BI ...

  4. Cancer Clinical Trials - Medical Professionals

    Bevacizumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such ...

  5. Hematology - Clinical trials

    Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...

  6. Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma - Mayo Clinic

    Imiquimod may stimulate the immune system. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread.

  7. Oncology (Medical) - Clinical trials

    ... monoclonal antibody, and compare them with clinical outcomes. Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss.

  8. Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study - Mayo Clinic

    Ramucirumab is a monoclonal antibody that may prevent the growth of new blood vessels that tumors need to grow. I. Participation eligibility. Participant ...

  9. Clinical trials - Oncology (Medical)

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

  10. Margetuximab-cmkb (intravenous route) - Side effects & uses - Mayo Clinic

    Margetuximab-cmkb is a monoclonal antibody that changes the immune system to help control the growth of cancer cells. This medicine is to be given only by ...